Investigational Use
in Approved Clinical Studies
The ClearPoint Neuro Navigation Platform for Drug Delivery and Gene Therapy*
The FDA-cleared and CE Marked ClearPoint Neuro Navigation System provides real-time MRI guidance for cannula placement. When combined with the SmartFlow® Cannula*, this can allow for assessment of infusion coverage and delivery of approved therapeutics to regions of interest in the brain in clinical trials.
*For investigational use only in approved clinical trials. Please refer to the appropriate device labeling for further details.
See How The ClearPoint Neuro Navigation System Enables Drug Delivery
Benefits of ClearPoint-Enabled CNS Infusions*
*For investigational use only in approved clinical trials. Please refer to the appropriate device labeling for further details.
The ClearPoint Neuro Navigation System and the SmartFlow Cannula Have Enabled Clinical Trials Across the Following Indications
Parkinson’s | Huntingtons | Neuromuscular Disorders | Rare Genetic Disorders |
Epilepsy | Neuro-Oncology
ClearPoint is Used to Deliver Biologics & Drugs in Clinical Trials With a Range of Partners, Including:
Educational Resources for Biologics & Drug Delivery
iMRI-Guided Gene Therapy and Drug Delivery for CNS Disorders
In this peer-reviewed publication, Dr. Paul Larson from UCSF discusses leveraging real-time MRI guidance for intracranial gene therapy administration and how it potentially improves efficacy and outcomes.
ClearPoint Bibliography
The ClearPoint Neuro Drug Delivery and Biologics Bibliography features ClearPoint being used in investigation and clinical research in many different peer-reviewed publications.
For any further questions on our educational resources, please reach out to our
Vice President of Translational and Pre-Clinical Research, Ernesto Salegio, PhD.